Average Co-Inventor Count = 2.83
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Roche Diagnostics Gmbh (5 from 480 patents)
2. Mikrogen Molekularbiologische Entwicklungs - Gmbh (3 from 7 patents)
3. Mikrogen Gmbh (3 from 4 patents)
4. Mikrogen Molekularbiologische Entwickslung-gmbh (1 from 1 patent)
5. Osterreichische Akademie Der Wissenschaften (3 patents)
12 patents:
1. 11169153 - Method for the normalization of immunological tests and kits for performing such tests
2. 10921323 - Method for the immunological diagnosis of a sample with a potential infection with an arbovirus and test kits suitable for this purpose
3. 8580521 - [object Object]
4. 7476498 - Peptides derived from capsid antigens of the Epstein-Barr virus and the use thereof
5. 7122302 - Method for determining early HCV seroconversion
6. 6808711 - Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines
7. 6610301 - Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines
8. 6306579 - Recombinant antigen from the NS3 region of the hepatitis C virus
9. 6274307 - Immunologically active peptides or polypeptides from the parvovirus B19
10. 6270960 - Recombinant antigen from the NS3 region of the hepatitis C virus
11. 6136527 - Polypeptides derived from proteins of the hepatitis C virus, test kits
12. 6096319 - Recombinant antigen from the NS3 region of the hepatitis C virus